Page last updated: 2024-12-07

heptakis(2,6-o-dimethyl)beta-cyclodextrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

heptakis(2,6-O-dimethyl)beta-cyclodextrin: stimulant for Bordetella pertussis Phase I [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10171019
CHEMBL ID2074619
SCHEMBL ID536969
MeSH IDM0114894

Synonyms (40)

Synonym
2,6-dme-beta-cyclodextrin
bdbm36245
heptakis-2,6-di-o-methyl-beta-cyclodextrin
heptakis(2,6-o-dimethyl)beta-cyclodextrin
beta-cyclodextrin, 2(sup a),2(sup b),2(sup c),2(sup d),2(sup e),2(sup f),2(sup g),6(sup a),6(sup b),6(sup c),6(sup d),6(sup e),6(sup f),6(sup g)-tetradeca-o-methyl-
beta-cyclodextrin, 2a,2b,2c,2d,2e,2f,2g,6a,6b,6c,6d,6e,6f,6g-tetradeca-o-methyl-
heptakis(2,6-di-o-methyl)-beta-cyclodextrin
heptakis(2,6-di-o-methyl)-beta-cyclodextrin, >=98.0% (tlc)
51166-71-3
2,6-di-o-methyl-beta-cyclodextrin
unii-5fjp73e35o
2,6-beta-o-dimethylcyclodextrin
5fjp73e35o ,
CHEMBL2074619
2,6-di-o-methyl-|a-cyclodextrin
SCHEMBL536969
2,6-di-o-methyl-beta-cd
J-700013
2,6-dimethyl-beta-cyclodextrin
W-202928
2,6-dimethyl-b-cyclodextrin
2,6-dimethyl-.beta.-cyclodextrin
heptakis(2,6-di-o-methyl)-.beta.-cyclodextrin
.beta.-cyclodextrin, 2a,2b,2c,2d,2e,2f,2g,6a,6b,6c,6d,6e,6f,6g-tetradeca-o-methyl-
2,6-di-o-methyl-.beta.-cyclodextrin
tetradecakis-2,6-o-methylcycloheptaamylose
heptakis(2 6-di-o-methyl)-b-cyclodextrin
QGKBSGBYSPTPKJ-UZMKXNTCSA-N
heptakis(2,6-di-o-methyl)-beta-cyclodextrin; contains trimethyl-beta-cyclodextrin
AS-10618
A871354
di-o-methyl-beta-cyclodextrin
Q27261971
AKOS037643206
26-di-o-methyl-beta-cyclodextrin
DTXSID501311203
CS-0137271
AC-36714
HY-137234
2,6-dimethyl--cyclodextrin

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Cell toxicity of methylated-beta-CDs was the highest, while ionic derivatives proved to be less toxic than methylated ones."( Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.
Bácskay, I; Fenyvesi, E; Fenyvesi, F; Iványi, R; Kiss, T; Szente, L; Tósaki, A; Váradi, J; Vecsernyés, M, 2010
)
0.36
" Cyclodextrins, which are most commonly used to reduce the undesirable features of contained drugs within their hydrophobic interior, also have the potential to alter the toxic behavior of the drug."( The Interaction of Heptakis (2,6-di-O-Methyl)-β-cyclodextrin with Mianserin Hydrochloride and Its Influence on the Drug Toxicity.
Belica-Pacha, S; Bryszewska, M; Budryn, G; Daśko, M; Małecka, M; Miłowska, K; Oracz, J; Pałecz, B, 2021
)
0.62

Pharmacokinetics

ExcerptReferenceRelevance
" Dissolution and pharmacokinetic studies indicated that the simvastatin/DMβCD complex exhibited an increased dissolution rate, rapid absorption, and improved bioavailability in rats compared to free drug."( Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
Fan, H; Gu, F; Ning, J; Wang, Y; Wu, C, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" Differences in bioavailability may have resulted from differences in experimental animal conditions."( Nasal absorption enhancement of 17 beta-estradiol by dimethyl-beta-cyclodextrin in rabbits and rats.
Deurloo, MJ; Hermens, WA; Merkus, FW; Romeyn, SG; Verhoef, JC, 1990
)
0.28
"Methodology and the results of the in vitro membrane diffusion and in vivo bioavailability studies are presented."( Formulation of diazepam containing rectal suppositories and experiences of their biopharmaceutical study.
Bácskay, I; Bálint, GS; Kata, M; Regdon, G; Sánta, A; Selmeczi, B; Szikszay, M, 1994
)
0.29
" Without additives the nasal bioavailability of the peptide was in the order of 15 and 10% in rats and rabbits, respectively."( Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.
Brakkee, JH; De Lannoy, LM; Gispen, WH; Merkus, FW; Romeijn, SG; Schipper, NG; Verhoef, JC; Wiegant, VM, 1993
)
0.29
" The absolute bioavailability of the nasally administered insulin/DM beta CD powder was 13 +/- 4%, compared to 1 +/- 1% for both an insulin/DM beta CD liquid and an insulin/lactose powder formulation."( Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
Merkus, FW; Romeijn, SG; Schipper, NG; Verhoef, JC, 1993
)
0.29
" From the values of K beta-CD:SA- = (105 +/- 15)M-1 and KDIMEB:SA- = (140 +/- 20)M-1 obtained, the bioavailability of the salicylate drug in the complexed form has been discussed."( Binding of sodium salicylate by beta-cyclodextrin or 2,6-di-O-methyl-beta-cyclodextrin in aqueous solution.
Aicart, E; Junquera, E; Peña, L, 1998
)
0.3
" The variability of bioavailability of DM-beta-CyD complex was lower than that of Sandimmune, although the extent of bioavailability of DM-beta-CyD was only a little higher than that of Sandimmune."( Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.
Arima, H; Hirayama, F; Irie, T; Miyake, K; Uekama, K, 1999
)
0.3
"We recently reported that of all hydrophilic cyclodextrin (CyD) derivatives examined, 2,6-di-O-methyl-beta-cyclodextrin (DM-beta-CyD) most significantly increased the aqueous solubility and the dissolution rate, resulting in the improvement of oral bioavailability of the immunosuppressive drug tacrolimus in rats."( Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima, H; Hirayama, F; Uekama, K; Yunomae, K, 2001
)
0.31
" The relative bioavailability of insulin formulations containing TDM was higher (0."( Pulmonary absorption of insulin mediated by tetradecyl-beta-maltoside and dimethyl-beta-cyclodextrin.
Ahsan, F; Hussain, A; Yang, T; Zaghloul, AA, 2003
)
0.32
"The purpose of this investigation was to study the influences of absorption enhancers in increasing oral bioavailability of Ganciclovir (GAN) by assessing the transepithelial permeation across cell monolayers in vitro and bioavailability in rats in vivo."( Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Bagchi, T; Jogani, V; Mishra, AK; Mishra, P; Misra, A; Shah, P, 2007
)
0.34
" Significantly improved permeation of acyclovir in the presence of selected combinations of absorption enhancers may be used as a viable approach in overcoming the problem of limited oral bioavailability of acyclovir."( In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Bagchi, T; Jogani, V; Mishra, AK; Mishra, P; Misra, A; Shah, P, 2008
)
0.35
" In vivo studies showed the absolute bioavailability of 25."( Effect of dimethyl-beta-cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats.
Esmaily, H; Gilani, K; Jalalipour, M; Najafabadi, AR; Tajerzadeh, H, 2008
)
0.35
"The study was designed to investigate the effect of cyclodextrins (CDs) on the solubility, dissolution rate, and bioavailability of cilostazol by forming inclusion complexes."( Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel, SG; Rajput, SJ, 2009
)
0.35
" It is an ionizable drug, whose solubility depends on the gastrointestinal pH, and the bioavailability is therefore very variable."( Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.
Aigner, Z; Balogh, Á; Blazsó, G; Mándity, I; Martinek, T; Sipos, P; Szabados-Nacsa, A; Szabó-Révész, P, 2011
)
0.37
" However, poor trans-mucosal permeability of large macromolecular antigens limits bioavailability to local inductive immune cells."( Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines.
Klein, K; Mann, JF; Rogers, P; Shattock, RJ, 2014
)
0.4
" However, its oral bioavailability is greatly limited by the dissolution rate of the drug."( Characterization and In Vitro Evaluation of the Complexes of Posaconazole with β- and 2,6-di-O-methyl-β-cyclodextrin.
Li, H; Liao, X; Ma, X; Tang, P; Wang, L; Xiong, X; Xu, K, 2017
)
0.46
" In the case of acyclovir, Cap-Na either alone or in combination with SLS or chitosan has the potential to improve its absorption and bioavailability and has yet to be explored."( Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates, M; Kaynak, MS; Sahin, S, 2016
)
0.43
"Simvastatin is poorly bioavailable because it is practically insoluble in water and shows dissolution rate-limited absorption."( Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
Fan, H; Gu, F; Ning, J; Wang, Y; Wu, C, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" From a practical point of view, 2 seems to be particularly useful for improving the pharmaceutical properties of flurbiprofen in various dosage forms."( Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
Hirayama, F; Imai, T; Irie, T; Maeda, T; Otagiri, M; Uekama, K, 1985
)
0.27
" On the other hand, nasal administration of the lyophilized insulin/DM beta CD powder dosage form in rabbits resulted in increased serum insulin concentrations, and a maximum decrease in blood glucose of about 50%."( Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
Merkus, FW; Romeijn, SG; Schipper, NG; Verhoef, JC, 1993
)
0.29
"Nifedipine is a highly photosensitive drug that requires restricted protection from light during manufacturing, storage and handling of its dosage forms."( Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
Abanumay, KA; Al-Angary, AA; Bayomi, MA, 2002
)
0.31
"There is a need for nasal drug delivery of metoclopramide HCI (MTC) in specific patient populations where the use of commercially available intravenous and oral dosage forms may be inconvenient and/or unfeasible."( Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation.
Altunay, H; Ozkan, CK; Ozkan, Y; Savaser, A; Tas, C; Tasdemir, U, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID679125TP_TRANSPORTER: transepithelial transport of Rhodamine 123 (basal to apical) in Caco-2R cells2004Pharmaceutical research, Apr, Volume: 21, Issue:4
Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (145)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (6.21)18.7374
1990's34 (23.45)18.2507
2000's50 (34.48)29.6817
2010's46 (31.72)24.3611
2020's6 (4.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other148 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]